Terms: = Bone cancer AND ARID2, ENSG00000189079, 196528, Q68CP9, p200, KIAA1557, FLJ30619, DKFZp779P0222, DKFZp686G052, BAF200 AND Treatment
2 results:
1. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
2. Neutrophil elastase-mediated proteolysis of the tumor suppressor p200 CUX1 promotes cell proliferation and inhibits cell differentiation in APL.
Yu L; Zhong L; Xiong L; Dan W; Li J; Ye J; Wan P; Luo X; Chu X; Liu C; He C; Mu F; Liu B
Life Sci; 2020 Feb; 242():117229. PubMed ID: 31887298
[TBL] [Abstract] [Full Text] [Related]
